Exchange: NASDAQ·Updated 07:30 PM EDT
NXTC logo

NXTC Nextcure Inc

$7.07
$0.40
(5.90%)
Today
Closed $7.18
$0.11
(1.53%)
After Hours
Reported EarningsAug 6
Mkt Cap$31.03M
Vol85,745.00

About NXTC

NextCure, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases. Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines. The company was founded by Michael S. Richman and Lie Ping Chen in September 2015 and is headquartered in Beltsville, MD.
62

Bullish Sentiment

How do you feel about NXTC?

stockpicker63
$NXTC is a high-risk, high-reward speculative play. For Traders: The technical setup suggests the stock is building a base near strong support ($5.00–$5.10). A momentum trade could be considered on a high-volume breakout above $7.55, with a strict stop-loss below $4.90 to manage the inherent volatility. For Investors: The fundamental thesis hinges entirely on the clinical success of its ADC pipeline (particularly SIM0505) and the company’s ability to reach its next major value-inflection point before needing to raise additional capital. The massive gap between the current price and analyst price targets reflects the binary nature of biotech investing: success could lead to a major re-rating or buyout, while failure could result in severe downside.
1
INEEDMONEY87
$NXTC this has had maxed short interest multiple times after the RM, i would be super careful in that direction. super low volume individuals do affect it and the spread can get wild here, not sure there are legit MMs providing liquidity or just randomly placed algo orders…. the whole board gets pretty weird at times

Advertisement|Remove ads.